{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:27:05Z","timestamp":1778084825106,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatocellular carcinoma (HCC) is a significant health concern, ranking as the fourth most common cancer in Egypt and the sixth globally. Research has identified over 300 single nucleotide polymorphisms (SNPs) in the ghrelin gene, with four of these SNPs being associated with pathogenicity. The current work is a pioneer attempt to evaluate the role of Ghrelin gene polymorphism as a risk factor for progression of chronic viral hepatitis to cirrhosis and hepatocellular carcinoma in Egyptian patients. This study was carried out on 80 cases and were allocated into four groups: Group I: apparently healthy individuals, Group II: patients with chronic viral hepatitis, Group III: patients with post-hepatitic cirrhosis, and Group IV: patients with viral hepatitis-related HCC. Serum Ghrelin was measured by ELISA Kit. Molecular detection of Ghrelin rs34911341 and rs696217 were assessed using DNA sequencing. Outcomes showed that in terms of ghrelin gene polymorphism, every group under study had a GG rs34911341. The frequency of rs696217 genotype CA was statistically significantly higher in controls than in cirrhotic and HCC cases. When cirrhosis and HCC cases were compared to controls and chronic active hepatitis cases, the serum ghrelin level decreased statistically significantly. Taken together, there was no relation of ghrelin gene polymorphism in rs34911341 with progression of chronic active hepatitis. Moreover, the frequency of rs696217 genotype CA was increased in controls compared to patients with chronic viral hepatitis and patients with viral hepatitis-related HCC. Compared to controls, liver disease patients had lower serum Ghrelin levels.<\/jats:p>","DOI":"10.1038\/s41598-025-99037-1","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:46:28Z","timestamp":1746701188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of ghrelin serum level and gene polymorphism as a risk factor in progression of chronic viral hepatitis"],"prefix":"10.1038","volume":"15","author":[{"given":"Lamiaa Mahmoud","family":"Kamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagwa Mohamed","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal A","family":"Jouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany Mohamed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba H.","family":"Mahboub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif Y.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"9","key":"99037_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/1348-0421.12916","volume":"65","author":"A Elbahrawy","year":"2021","unstructured":"Elbahrawy, A. et al. Current situation of viral hepatitis in Egypt. Microbiol. Immunol. 65(9), 352\u2013372. https:\/\/doi.org\/10.1111\/1348-0421.12916 (2021).","journal-title":"Microbiol. Immunol."},{"key":"99037_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s43066-024-00362-3","volume":"14","author":"W Abdelhamed","year":"2024","unstructured":"Abdelhamed, W. & El-Kassas, M. Hepatitis B virus in Egypt: the whole story. Egypt. Liver J. 14, 56. https:\/\/doi.org\/10.1186\/s43066-024-00362-3 (2024).","journal-title":"Egypt. Liver J."},{"key":"99037_CR3","doi-asserted-by":"crossref","unstructured":"Foglia, B., Turato, C. & Cannito, S. Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment. Int. J. Mol. Sci. 24(15), 12224 (2023).","DOI":"10.3390\/ijms241512224"},{"key":"99037_CR4","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","DOI":"10.3322\/caac.21763"},{"issue":"3","key":"99037_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/biom14030264","volume":"14","author":"O Al Musaimi","year":"2024","unstructured":"Al Musaimi, O. Exploring FDA-Approved Frontiers: Insights into natural and engineered peptide analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and \u03b1-MSH realms. Biomolecules 14(3), 264. https:\/\/doi.org\/10.3390\/biom14030264 (2024).","journal-title":"Biomolecules"},{"issue":"19","key":"99037_CR6","doi-asserted-by":"publisher","first-page":"11188","DOI":"10.3390\/ijms231911188","volume":"23","author":"A Kasprzak","year":"2022","unstructured":"Kasprzak, A. & Adamek, A. Role of the Ghrelin system in colitis and hepatitis as risk factors for Inflammatory-Related cancers. Int. J. Mol. Sci. 23(19), 11188. https:\/\/doi.org\/10.3390\/ijms231911188 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"99037_CR7","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.jksus.2022.102393","volume":"35","author":"MS Al-Nbaheen","year":"2023","unstructured":"Al-Nbaheen, M. S. Relationship between single nucleotide polymorphism studies in Ghrelin gene with obesity subjects. J. King Saud Univ. - Sci. 35(1), 102393. https:\/\/doi.org\/10.1016\/j.jksus.2022.102393 (2023).","journal-title":"J. King Saud Univ. - Sci."},{"issue":"11","key":"99037_CR8","doi-asserted-by":"publisher","first-page":"e0143069","DOI":"10.1371\/journal.pone.0143069","volume":"10","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Zhai, L., Rong, C., Qin, X. & Li, S. Association of Ghrelin gene polymorphisms and serum Ghrelin levels with the risk of hepatitis B Virus-Related liver diseases in a Chinese population. PLoS One. 10(11), e0143069. https:\/\/doi.org\/10.1371%2Fjournal.pone.0143069 (2015).","journal-title":"PLoS One"},{"issue":"1","key":"99037_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/enr-2023-0021","volume":"57","author":"A Prodan","year":"2023","unstructured":"Prodan, A. et al. Effect of the GHRL gene (rs696217) polymorphism on the metabolic disorders in patients with obesity in the Ukrainian population. Endocr. Regul. 57(1), 173\u2013182. https:\/\/doi.org\/10.2478\/enr-2023-0021 (2023).","journal-title":"Endocr. Regul."},{"issue":"19","key":"99037_CR10","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1200\/jco.21.02373","volume":"40","author":"PJ Johnson","year":"2022","unstructured":"Johnson, P. J., Pinato, D. J., Kalyuzhnyy, A. & Toyoda, H. Breaking the Child-Pugh dogma in hepatocellular carcinoma. J. Clin. Oncol. 40(19), 2078\u20132082. https:\/\/doi.org\/10.1200\/jco.21.02373 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"99037_CR11","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.3390\/jcm11226654","volume":"11","author":"Z Jamil","year":"2022","unstructured":"Jamil, Z. et al. Score and Glasgow Blatchford score to predict the In-Hospital outcome of portal hypertensive patients presenting with upper Gastrointestinal bleeding: an experience from tertiary healthcare system. J. Clin. Med. 11(22), 6654. https:\/\/doi.org\/10.3390\/jcm11226654 (2022).","journal-title":"J. Clin. Med."},{"key":"99037_CR12","doi-asserted-by":"publisher","unstructured":"Morgan, M. et al. Liver cancer (BCLC staging). Reference article, Radiopaedia.org. https:\/\/doi.org\/10.53347\/rID-34362(Accessed on 15 Nov 2024) .","DOI":"10.53347\/rID-34362"},{"issue":"4","key":"99037_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/liv.15843","volume":"44","author":"A Kandeel","year":"2024","unstructured":"Kandeel, A. et al. Evidence for the elimination of viral hepatitis B and C in Egypt: results of a nationwide survey in 2022. Liver Int. 44(4), 955\u2013965. https:\/\/doi.org\/10.1111\/liv.15843 (2024).","journal-title":"Liver Int."},{"issue":"5","key":"99037_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/jcag\/gwae025","volume":"7","author":"F Jaber","year":"2024","unstructured":"Jaber, F., Cholankeril, G. & El-Serag, H. B. Contemporary epidemiology of hepatocellular carcinoma: Understanding risk factors and surveillance strategies. J. Can. Association Gastroenterol. 7(5), 331\u2013345. https:\/\/doi.org\/10.1093\/jcag\/gwae025 (2024).","journal-title":"J. Can. Association Gastroenterol."},{"issue":"1","key":"99037_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v11.i1.1","volume":"11","author":"A Desai","year":"2019","unstructured":"Desai, A., Sandhu, S., Lai, J. P. & Sandhu, D. S. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J. Hepatol. 11(1), 1\u201318. https:\/\/doi.org\/10.4254\/wjh.v11.i1.1 (2019).","journal-title":"World J. Hepatol."},{"issue":"7","key":"99037_CR16","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ijms18071392","volume":"18","author":"C Buechler","year":"2017","unstructured":"Buechler, C., Haberl, E. M., Rein-Fischboeck, L. & Aslanidis, C. Adipokines in liver cirrhosis. Int. J. Mol. Sci. 18(7), 1392. https:\/\/doi.org\/10.3390\/ijms18071392 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"99037_CR17","doi-asserted-by":"publisher","first-page":"78380","DOI":"10.1155\/mi\/2006\/78380","volume":"2006","author":"H Ataseven","year":"2006","unstructured":"Ataseven, H. et al. The levels of Ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006(4), 78380. https:\/\/doi.org\/10.1155\/mi\/2006\/78380 (2006).","journal-title":"Mediators Inflamm."},{"key":"99037_CR18","doi-asserted-by":"publisher","unstructured":"Chen, Y. C. et al. High-normal and abnormal Alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C. J. Formos. Med. Assoc. https:\/\/doi.org\/10.1016\/j.jfma.2025.01.026 (2025).","DOI":"10.1016\/j.jfma.2025.01.026"},{"key":"99037_CR19","doi-asserted-by":"crossref","unstructured":"Elaghori, A., Salem, P. E. S., Azzam, E. & Abu Elfotoh, N. Ghrelin level in patients with liver cirrhosis. Acta Endocrinol. (Buchar). 5(1), 62\u201368  (2019).","DOI":"10.4183\/aeb.2019.62"},{"issue":"10","key":"99037_CR20","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/liv.12235","volume":"33","author":"T Kawaguchi","year":"2013","unstructured":"Kawaguchi, T., Nagao, Y. & Sata, M. Independent factors associated with altered plasma active Ghrelin levels in HCV-infected patients. Liver Int. 33(10), 1510\u20131516. https:\/\/doi.org\/10.1111\/liv.12235 (2013).","journal-title":"Liver Int."},{"issue":"2","key":"99037_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.gene.2013.06.053","volume":"527","author":"TK Motawi","year":"2013","unstructured":"Motawi, T. K., Shaker, O. G., Ismail, M. F. & Sayed, N. H. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients. Gene 527(2), 516\u2013520. https:\/\/doi.org\/10.1016\/j.gene.2013.06.053 (2013).","journal-title":"Gene"},{"issue":"4","key":"99037_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/s0168-8278(02)00438-5","volume":"38","author":"F Tacke","year":"2003","unstructured":"Tacke, F. et al. Ghrelin in chronic liver disease. J. Hepatol. 38(4), 447\u2013454. https:\/\/doi.org\/10.1016\/s0168-8278(02)00438-5 (2003).","journal-title":"J. Hepatol."},{"issue":"4","key":"99037_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/00365511003763349","volume":"70","author":"AM El-Shehaby","year":"2010","unstructured":"El-Shehaby, A. M., Obaia, E. M., Alwakil, S. S. & Hiekal, A. A. Total and acylated Ghrelin in liver cirrhosis: correlation with clinical and nutritional status. Scand. J. Clin. Lab. Invest. 70(4), 252\u2013258. https:\/\/doi.org\/10.3109\/00365511003763349 (2010).","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"99037_CR24","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1210\/jc.2004-1788","volume":"90","author":"JM Garcia","year":"2005","unstructured":"Garcia, J. M. et al. Active Ghrelin levels and active to total Ghrelin ratio in cancer-induced cachexia. J. Clin. Endocrinol. Metab. 90(5), 2920\u20132926. https:\/\/doi.org\/10.1210\/jc.2004-1788 (2005).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99037-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:46:30Z","timestamp":1746701190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99037"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99037-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations of the National Institutes of Health\u2019s recommendations. The study was granted permission by the Faculty of Medicine Institutional Review Board (Zagazig University) (IRB#5484-16-7-2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"16052"}}